Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry
- 27 November 2003
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 324 (2) , 276-284
- https://doi.org/10.1016/j.ab.2003.09.038
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteinsPublished by Wiley ,2003
- The role of taxanes in the adjuvant treatment of early stage breast cancer.Breast Cancer Research and Treatment, 2003
- Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.Cancer Investigation, 2003
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping StrategiesJournal of Clinical Oncology, 2002
- Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxelAnti-Cancer Drugs, 2002
- Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid–liquid extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for DocetaxelInvestigational New Drugs, 2001
- A Sensitive Docetaxel Assay in Plasma by Solid-Phase Extraction and High Performance Liquid Chromatography – UV Detection: Validation and Suitability in Phase I Clinical Trial PharmacokineticsInvestigational New Drugs, 1999
- Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liverPharmacogenetics, 1998